Jeevan Scientific Technologyの配当性向
Jeevan Scientific Technologyの配当性向は何ですか。
Jeevan Scientific Technology Limitedの配当性向はN/Aです。
配当性向の定義は何ですか。
配当性向は、株主への配当で支払われる利益の割合です。
The payout ratio is calculated by dividing the dividends paid out by the net earnings for a certain period. It is usually expressed as a percentage. The part of the earnings not paid to investors is left for investment to provide for future earnings growth. Investors seeking high current income and limited capital growth prefer companies with high payout ratio. However investors seeking capital growth may prefer lower payout ratio because capital gains are taxed at a lower rate. High growth firms in early life generally have low or zero payout ratios. As they mature, they tend to return more of the earnings back to investors.
Jeevan Scientific Technologyは何をしますか。
Jeevan Scientific Technology Limited engages in the clinical research, data management, and information technology businesses in India. The company's services include BA/BE studies that comprise bioanalytical and clinical services, pharmacokinetic and bio-statistics, and glucose clamping; clinical trial services, such as medical writing, clinical trial management and monitoring, drug safety and clinical data management, biostatistics and statistical programming, and quality assurance; and pharmacovigilance services, including ICSR management, aggregate safety reports, risk management plan, signal detection, medical information call center, and other integrated services. It also provides services in the areas of test assessment, test center of excellence, process establishment, and functional and non-functional testing. The company was formerly known as Jeevan Softech Limited and changed its name to Jeevan Scientific Technology Limited in March 2011. Jeevan Scientific Technology Limited was founded in 1999 and is based in Hyderabad, India.